blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3481952

EP3481952 - LEUKEMIA METHYLATION MARKERS AND USES THEREOF [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  20.07.2023
Database last updated on 15.06.2024
FormerRequest for examination was made
Status updated on  12.04.2019
FormerThe international publication has been made
Status updated on  12.01.2018
Most recent event   Tooltip01.06.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Youhealth Biotech, Limited
Suite 4-210 Governors Square
23 Lime Tree Bay Avenue
Grand Cayman KYI-1209 / KY
For all designated states
The Regents of the University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607 / US
[2019/20]
Inventor(s)01 / ZHANG, Kang
14329 San Dieguito Road
San Diego, CA 92130 / US
02 / HOU, Rui
17
Hunnan District
Pujiangyuan Shenyang 110000 / CN
03 / ZHENG, Lianghong
17
Hunnan District
Pujiangyuan Shenyang 110000 / CN
 [2019/20]
Representative(s)HGF
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
[N/P]
Former [2019/20]HGF Limited
8th Floor
140 London Wall
London EC2Y 5DN / GB
Application number, filing date17824912.406.07.2017
[2019/20]
WO2017US40953
Priority number, dateUS201662358762P06.07.2016         Original published format: US 201662358762 P
US20171543517416.02.2017         Original published format: US201715435174
[2019/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018009702
Date:11.01.2018
Language:EN
[2018/02]
Type: A1 Application with search report 
No.:EP3481952
Date:15.05.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 11.01.2018 takes the place of the publication of the European patent application.
[2019/20]
Search report(s)International search report - published on:US11.01.2018
(Supplementary) European search report - dispatched on:EP18.03.2020
ClassificationIPC:C12N15/11, C12Q1/68, G01N33/574
[2019/20]
CPC:
C12Q1/6886 (EP,US); C12Q2600/106 (EP,US); C12Q2600/154 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/20]
TitleGerman:LEUKÄMIEMETHYLIERUNGSMARKER UND VERWENDUNGEN DAVON[2019/20]
English:LEUKEMIA METHYLATION MARKERS AND USES THEREOF[2019/20]
French:MARQUEURS DE MÉTHYLATION DANS LE TRAITEMENT DE LA LEUCÉMIE ET LEURS UTILISATIONS[2019/20]
Entry into regional phase06.02.2019National basic fee paid 
06.02.2019Search fee paid 
06.02.2019Designation fee(s) paid 
06.02.2019Examination fee paid 
Examination procedure06.02.2019Examination requested  [2019/20]
19.10.2020Amendment by applicant (claims and/or description)
19.07.2023Despatch of a communication from the examining division (Time limit: M04)
15.11.2023Reply to a communication from the examining division
Fees paidRenewal fee
15.07.2019Renewal fee patent year 03
14.07.2020Renewal fee patent year 04
15.07.2021Renewal fee patent year 05
26.05.2022Renewal fee patent year 06
29.05.2023Renewal fee patent year 07
30.05.2024Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2007016668  (SEQUENOM INC [US], et al)[A] 1-15;
 [I]US2009264306  (CALDWELL CHARLES W [US], et al) [I] 1-13 * the whole document *;
 [A]  - XIAOLONG SHI ET AL, "Multiplex detection of CpG methylation using microarray combining with target-selection-padlock probe", CLINICA CHIMICA ACTA, ELSEVIER BV, AMSTERDAM, NL, vol. 411, no. 17, doi:10.1016/J.CCA.2010.03.026, ISSN 0009-8981, (20100319), pages 1187 - 1194, (20100327), XP028147852 [A] 1-15

DOI:   http://dx.doi.org/10.1016/j.cca.2010.03.026
International search[A]US2011287968  (WEINHAUSEL ANDREAS [AT], et al) [A] 1, 5-24 * entire document *;
 [A]US2009203588  (WILLMAN CHERYL L [US], et al) [A] 1, 5-24 * entire document *;
 [A]US2009264306  (CALDWELL CHARLES W [US], et al) [A] 1, 5-24 * entire document *;
 [A]  - JOHNSON et al., "DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer", Clinical Epigenetics, (20150725), pages 1 - 12, XP055450700 [A] 1, 5-24 * . entire document *

DOI:   http://dx.doi.org/10.1186/s13148-015-0094-0
 [PA]  - HAO et al., "DNA methylation markers for diagnosis and prognosis of common cancers", Proceedings of the National Academy of Sciences of the United States of America, (20170626), vol. 114, no. 28, pages 7414 - 7419, XP055450701 [PA] 1, 5-24 * . entire document *

DOI:   http://dx.doi.org/10.1073/pnas.1703577114
 [PA]  - BYUN et al., "Impact of Chromosomal Rearrangement upon DNA Methylation Patterns in Leukemia", Open Med (Wars, (20170504), vol. 12, pages 76 - 85, XP055450702 [PA] 1, 5-24 * . entire document *

DOI:   http://dx.doi.org/10.1515/med-2017-0014
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.